File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: High dose insulin for treatment of calcium channel blocker overdose: a case series

TitleHigh dose insulin for treatment of calcium channel blocker overdose: a case series
Authors
Issue Date2017
PublisherExcerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinthera
Citation
The 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Prague, Czech Republic, 24-27 June 2017. In Clinical Therapeutics, 2017, v. 39 n. 8S, p. e34 How to Cite?
AbstractBackground: Calcium channel blocker (CCB) overdose may cause hypotension, shock and death. There has been limited evidence on the efficacy of high dose insulin (HDI) as supportive therapy for calcium channel blocker overdose patients. Therefore, we characterised and studied the survival of patients treated with HDI following a calcium channel blocker overdose. Methods: The Poison Information and Clinical Management System was used to identify patients with CCB overdose. For inclusion, patients must be documented to have CCB overdose and hypotension despite calcium salt infusion. Patients were stratified into two groups - with or without HDI treatment. The primary outcome was all-cause mortality. Results were analysed using SPSS version 23.0. Results: Seventeen patients were included in this study. Fifteen (88.0%) patients were diagnosed with hypertension. Four (23.5%) and five (29.4%) patients had diagnosis of a psychiatric disorder and diabetes mellitus, respectively. Six (35.3%) patients also took an overdose of anti-hypertensive medication. The mortality rates of patients were 38.5% and 0% in patients with or without HDI treatment, respectively (P=0.152). There was no significant difference in the time-to-event relationship with respect to all-cause mortality (P=0.594). Conclusions: CCB overdose can be fatal. HDI did not improve survival in patients with CCB overdose.
Persistent Identifierhttp://hdl.handle.net/10722/247882
ISSN
2015 Impact Factor: 2.925
2015 SCImago Journal Rankings: 0.997

 

DC FieldValueLanguage
dc.contributor.authorTsoi, MF-
dc.contributor.authorCheung, BMY-
dc.contributor.authorCheung, TT-
dc.date.accessioned2017-10-18T08:34:11Z-
dc.date.available2017-10-18T08:34:11Z-
dc.date.issued2017-
dc.identifier.citationThe 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Prague, Czech Republic, 24-27 June 2017. In Clinical Therapeutics, 2017, v. 39 n. 8S, p. e34-
dc.identifier.issn0149-2918-
dc.identifier.urihttp://hdl.handle.net/10722/247882-
dc.description.abstractBackground: Calcium channel blocker (CCB) overdose may cause hypotension, shock and death. There has been limited evidence on the efficacy of high dose insulin (HDI) as supportive therapy for calcium channel blocker overdose patients. Therefore, we characterised and studied the survival of patients treated with HDI following a calcium channel blocker overdose. Methods: The Poison Information and Clinical Management System was used to identify patients with CCB overdose. For inclusion, patients must be documented to have CCB overdose and hypotension despite calcium salt infusion. Patients were stratified into two groups - with or without HDI treatment. The primary outcome was all-cause mortality. Results were analysed using SPSS version 23.0. Results: Seventeen patients were included in this study. Fifteen (88.0%) patients were diagnosed with hypertension. Four (23.5%) and five (29.4%) patients had diagnosis of a psychiatric disorder and diabetes mellitus, respectively. Six (35.3%) patients also took an overdose of anti-hypertensive medication. The mortality rates of patients were 38.5% and 0% in patients with or without HDI treatment, respectively (P=0.152). There was no significant difference in the time-to-event relationship with respect to all-cause mortality (P=0.594). Conclusions: CCB overdose can be fatal. HDI did not improve survival in patients with CCB overdose.-
dc.languageeng-
dc.publisherExcerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinthera-
dc.relation.ispartofClinical Therapeutics-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleHigh dose insulin for treatment of calcium channel blocker overdose: a case series-
dc.typeConference_Paper-
dc.identifier.emailCheung, BMY: mycheung@hku.hk-
dc.identifier.emailCheung, TT: tcheungt@hku.hk-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.authorityCheung, TT=rp01682-
dc.identifier.doi10.1016/j.clinthera.2017.05.106-
dc.identifier.hkuros282102-
dc.identifier.volume39-
dc.identifier.issue8S-
dc.identifier.spagee34-
dc.identifier.epagee34-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats